Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
31566 | 121 | 27.2 | 46% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
2598 | 3136 | RIBONUCLEOTIDE REDUCTASE//TRIMIDOX//DIDOX |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CRISNATOL | Author keyword | 4 | 75% | 2% | 3 |
2 | PHARMACODYNAMIC ANALYSIS | Author keyword | 1 | 38% | 2% | 3 |
3 | ARYLMETHYLAMINOPROPANEDIOL | Author keyword | 1 | 100% | 2% | 2 |
4 | ARYLMETHYLAMINOPROPANEDIOLS | Author keyword | 1 | 100% | 2% | 2 |
5 | AMAPS | Author keyword | 1 | 50% | 1% | 1 |
6 | DNA PROTEIN CYCLE | Author keyword | 1 | 50% | 1% | 1 |
7 | INTRAARTERIAL TREATMENT | Author keyword | 1 | 50% | 1% | 1 |
8 | HISTONE SYNTHESIS | Author keyword | 1 | 29% | 2% | 2 |
9 | CELLULAR RESPONSES TO ANTICANCER DRUGS | Author keyword | 0 | 33% | 1% | 1 |
10 | REDOX SENSITIVE TRANSCRIPTION FACTOR | Author keyword | 0 | 33% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BW A770U | 3 | 100% | 2% | 3 |
2 | AMAP | 3 | 60% | 2% | 3 |
3 | INVITRO PHARMACODYNAMIC ASSAY | 2 | 67% | 2% | 2 |
4 | SINGLE DOSE SCHEDULE | 2 | 67% | 2% | 2 |
5 | ARYLMETHYLAMINOPROPANEDIOLS AMAP | 1 | 50% | 2% | 2 |
6 | CLINICAL PHARMACOLOGY TRIAL | 1 | 100% | 2% | 2 |
7 | CULTURED L5178Y CELLS | 1 | 50% | 1% | 1 |
8 | HYDROXYUREA TERATOGENESIS | 1 | 50% | 1% | 1 |
9 | QSEC | 1 | 50% | 1% | 1 |
10 | MORPHONUCLEAR | 0 | 33% | 1% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
A morphological study of the effect of chlorambucil during the S and G2 phases of the cell cycle of synchronized HEp-2 cancer cell populations using computerized morphometry | 2000 | 1 | 31 | 16% |
CHEMOTHERAPEUTIC-AGENTS AND THE ERYTHRON | 1983 | 27 | 32 | 13% |
EXPLORING COWS MILK AND SOY PROTEIN SENSITIVITY IN HUMAN INFANTS | 1981 | 0 | 1 | 100% |
Hemolytic anemia and cancer | 1996 | 1 | 159 | 3% |
CELL-SEPARATION USING VELOCITY SEDIMENTATION AT UNIT GRAVITY AND BUOYANT DENSITY CENTRIFUGATION | 1989 | 1 | 17 | 6% |
NEW THERAPEUTIC STRATEGIES IN THE TREATMENT OF MURINE DISEASES INDUCED BY VIRUS AND SOLID TUMORS - BIOLOGY AND IMPLICATIONS FOR THE POTENTIAL TREATMENT OF HUMAN LEUKEMIA, AIDS, AND SOLID TUMORS | 1990 | 3 | 108 | 3% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ACCELERA | 0 | 25% | 0.8% | 1 |
2 | DAVID RUBENSTEIN PANCREAT CANC | 0 | 100% | 0.8% | 1 |
3 | RIBAVIRIN PREGNANCY REGISTRY | 0 | 100% | 0.8% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000131611 | BIOELECTROSTATICS//PORPHYRIN SCHIFF BASE//REGULATORY ACTION |
2 | 0.0000111606 | PHYSIOCOCHEM MED//REPROD ENDOCRINOL SIGNALING//W CHINA MED THORAC ONCOL |
3 | 0.0000108468 | HYDROXYUREA//GENET HUMAN THER Y//TARGET CELL AVAILABILITY |
4 | 0.0000103265 | EXPT TERATOL UNIT//BOUINS FLUID//GREY ZONE ANOMALIES |
5 | 0.0000081995 | MICROBIAL BIOTECHNOL CELL BIOL//INTERPHASE CHROMATIN//REVERSIBLE PERMEABILIZATION |
6 | 0.0000080412 | ELSAMICIN A//CHARTREUSIN//ELSAMITRUCIN |
7 | 0.0000075979 | MN II CATALYSED//RIBAVIRIN TRIPHOSPHATE//M ANISIDINE |
8 | 0.0000071552 | PEPTICHEMIO//ALKYLATING PEPTIDES//HUMAN MYELOMA CELLS |
9 | 0.0000070697 | FEULGEN STAINING//MORPHONUCLEAR CHARACTERISTICS//DIGITAL CELL IMAGE ANALYSIS |
10 | 0.0000065884 | ACTIVATED OXYGEN METABOLITES//MULTI NUCLEATED GIANT CELL//QUICK FREEZE |